Fairchem Organics Limited
Financial Performance Highlights
Q2 FY27 Results:
- Revenue from operations: ₹167 crores (49.7% year-on-year increase)
- EBITDA margin: 10.5%
- Net profit: ₹10.2 crores
- Raw material processed: 12,200 tons
- Products sold: 12,300 tons
- Realization: ₹135 per kg (compared to ₹130 per kg in Q1 FY27 and ₹106 per kg in Q2 FY26)
H1 FY27 Results:
- Revenue from operations: ₹343 crores (41.4% year-on-year increase)
- EBITDA: ₹35.4 crores
- EBITDA margin: 10.3%
- Net profit: ₹21.2 crores
- Raw material processed: 24,600 tons
- Products sold: 25,800 tons
Operational and Business Updates
Capacity Utilization:
- Current capacity utilization: 60-65%
- Expected improvement with better raw material availability
- Target: 5% capacity improvement every quarter
Market Conditions:
- Domestic market environment remained supportive
- Reduced imports/dumping of dimer acid from China (attributed to reduction in Chinese export incentives)
- Rupee depreciation helped export competitiveness
- Reduced US tariffs and potential benefits from free trade agreements with UK, Europe could improve export environment
Raw Material Developments:
- Recent reduction in import duty on Crude Soybean Oil from 16.5% to 11%
- Expected to improve raw material availability and potentially reduce prices
- Company carries some inventory of raw material
- Market prices have started softening
New Product Development:
- Novel technology product expected to launch in Q3 FY27 (after Diwali)
- Import substitution product with export potential
- Derivative of Fatty Acids/Dimer Acid
- Described as "very, very huge market" if successful
- Plant modifications and R&D ongoing, may face initial hiccups due to novel technology
Existing Products:
- PFAD bypass from palm oil has been commercialized
- Isostearic Acid facing headwinds in European cosmetic market due to market slowdown and regional strife
- Approval cycle for cosmetic applications typically takes 2-2.5 years
- Value-added products (Linoleic acid for oil field drilling, distilled dimer) offer 5-10% premium realization
Export Markets:
- US exports delayed due to high freight costs from India
- Waiting for freight rate stabilization to commence US exports
- European market facing challenges for cosmetic applications
Capital Expenditure and Expansion
- No immediate expansion plans for next 1-2 years
- Focusing on new product development first
- Will require capex if new product succeeds
- Land purchase of ₹12 crores was for existing operations and workers' colony (already in use)
Financial Management
- Working capital cycle: 90-100 days for domestic sales, higher for export sales
- No immediate plans to reduce debt
- Operating cash flow utilization to be decided once business stabilizes at higher levels
- Cost optimization efforts showing results with stable fuel and manufacturing costs despite inflation
Management Outlook
- Cautiously optimistic about outlook for remaining part of the year
- Expect to maintain and improve capacity utilization with better raw material availability
- Target EBITDA margin improvement to 15-18% (from current 10.5%)
- Monitoring developments in global trade, raw material markets, and import competition
- Believe Chinese dumping unlikely to restart
- Government not expected to increase import duties in near future due to inflation concerns
Conference Call Participants
Management Team: Nahoosh Jariwala (Managing Director and Chairman), Bhavesh Shah (Chief Financial Officer)
Analysts/Investors: Representatives from Discovery Capital, Counter Cyclical Investments, Girik Capital, ValueWise Wealth Management, and individual investors